Exicorilant Uses, Dosage, Side Effects and more
Exicorilant is under investigation in clinical trial NCT03437941 (Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With Mcrpc).
| Attribute | Details |
|---|---|
| Trade Name | Exicorilant |
| Generic | Exicorilant |
| Exicorilant Other Names | Exicorilant |
| Type | |
| Formula | C26H23F4N7O3S |
| Weight | Average: 589.57 Monoisotopic: 589.151921455 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
